Connor, Clark & Lunn Investment Management (CC&L)’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-57,965
Closed -$1.97M 1699
2024
Q2
$1.97M Sell
57,965
-46,665
-45% -$1.38M 0.01% 658
2024
Q1
$3.68M Buy
104,630
+70,763
+209% +$2.37M 0.02% 500
2023
Q4
$978K Buy
+33,867
New +$807K ﹤0.01% 866
2023
Q2
Sell
-22,689
Closed -$854K 1550
2023
Q1
$854K Sell
22,689
-7,731
-25% -$285K ﹤0.01% 756
2022
Q4
$814K Sell
30,420
-18,387
-38% -$503K ﹤0.01% 755
2022
Q3
$1.38M Buy
48,807
+20,418
+72% +$569K 0.01% 581
2022
Q2
$616K Buy
+28,389
New +$793K ﹤0.01% 729

Other funds holding MORF

Connor, Clark & Lunn Investment Management (CC&L)'s MORF Position: Q3 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 57,965 shares — an estimated $1.97M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in MORF in Q2 2022 and held it in 7 quarters. The position peaked at $3.68M in Q1 2024. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 57,965 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $1.97M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Morphic Holding, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Morphic Holding, Inc. Common Stock position peaked at $3.68M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2024, filed 8 Nov 2024.